Loutfy H. Madkour

Egypt Tanta University

讨论圈

评论了 Reactive Oxygen Species (ROS),
Discusses the effects of interactions between antioxidant defense therapy, ROS and strategies for treatment

讨论圈

评论了 Reactive Oxygen Species (ROS),
Covers recent advances in new nanomedication technologies for the effects of NPs on oxidative stress, ROS and ER stress

讨论圈

评论了 Reactive Oxygen Species (ROS),
Provides a better understanding of the mechanism of nanomaterial-induced toxicity as a first defense for hazard prevention

讨论圈

评论了 Reactive Oxygen Species (ROS),
Covers the ecotoxicology of environmental heavy metal ions and the interactions between specific heavy metals‒induced cell responses and oxidative stress

讨论圈

评论了 Nucleic Acids as Gene Anticancer Drug Delivery Therapy
Presents combination therapy as a new hope for enhancing current gene-based treatment efficacy

讨论圈

评论了 Nucleic Acids as Gene Anticancer Drug Delivery Therapy
Contains a comprehensive comparison of various delivery systems, listing their advantages and limitations

讨论圈

评论了 Nucleic Acids as Gene Anticancer Drug Delivery Therapy
Discusses intelligent drug delivery systems such as inorganic nanoparticles and polymer-based drug delivery

讨论圈

评论了 Nanoelectronic Materials Fundamentals and Applications
Principles of Computational Simulations Devices and Characterization of Nanoelectronic Materials

讨论圈

评论了 Nanoparticles Induce Oxidative and Endoplasmic Reticulum Stresses
Nanoparticles Induce Oxidative and Endoplasmic Reticulum Stresses: Antioxidant Therapeutic Defenses (Nanomedicine and Nanotoxicology)

讨论圈

评论了 Nanoparticle-Based Drug Delivery in Cancer Treatment
Focuses on material platforms that establish NPs and both localized and controlled gene silencing

讨论圈

评论了 Nanoparticle-Based Drug Delivery in Cancer Treatment
Reviews recent advances of nanoparticle-mediated siRNA delivery systems and their application in clinical trials for cancer therapy

讨论圈

评论了 RNA Delivery Function for Anticancer Therapeutics
Addresses various modifications and novel delivery strategies for miRNAs, piRNAs and siRNA delivery in anticancer therapeutics.